APIC Minnesota targets Carbapenem-resistant Enterobacteriaceae

The Minnesota chapter of APIC collaborated with the Minnesota Department of Health and the Centers for Disease Control and Prevention (CDC) on a successful effort to tackle Carbapenem-resistant Enterobacteriaceae (CRE).

CRE are bacteria that cause healthcare-associated infections (HAIs). They are resistant to almost all drugs, difficult to treat, and are associated with high death rates.

In 2010, APIC and the other partners developed recommendations and best practices for the prevention and control of CRE in acute care and long-term acute care hospitals in Minnesota. In 2011, these recommendations were tailored to meet the needs of long-term care facilities.

To date, no outbreaks or transmission of CRE have been reported among facilities that have conducted active surveillance testing. To learn more about the recommendations developed to guide Minnesota healthcare facilities in CRE prevention, visit the CDC’s website on “HAI Prevention Stories from the States.”